Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of neural transmission

• Publication date

  2009-05-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00702-009-0232-yPMID 19444377
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin E for neuroleptic-induced tardive dyskinesia.

  2011cited by this paper
• Effect of spirulina maxima on the haloperidol induced tardive dyskinesia and oxidative stress in rats

  2007cited by this paper
• Protective Efficacy of α-Lipoic Acid on Acetylcholinesterase Activity in Aged Rat Brain Regions

  2006cited by this paper
• Oxidative stress-mediated macromolecular damage and dwindle in antioxidant status in aged rat brain regions: role of L-carnitine and DL-alpha-lipoic acid.

  2006cited by this paper
• Translocation of AIF in the human and rat striatum following protracted haloperidol, but not clozapine treatment

  2006cited by this paper
• L-carnitine and alpha-lipoic acid improve age-associated decline in mitochondrial respiratory chain activity of rat heart muscle.

  2006cited by this paper
• Effect of chronic restraint stress and alpha-lipoic acid on lipid peroxidation and antioxidant enzyme activities in rat peripheral organs.

  2006cited by this paper
• Oxidative stress-mediated macromolecular damage and dwindle in antioxidant status in aged rat brain regions: Role of l-carnitine and dl-α-lipoic acid

  2006cited by this paper
• Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice.

  2005cited by this paper
• D1/D2 dopamine and N-methyl-d-aspartate (NMDA) receptor participation in experimental catalepsy in rats

  2005cited by this paper
• Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity.

  2005cited by this paper
• Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia

  2005cited by this paper
• Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose

  2005cited by this paper
• Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy.

  2004cited by this paper
• Oral dyskinesia in rats following brain lesions and neuroleptic drug administration

  2004cited by this paper
• Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol

  2004cited by this paper
• Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia.

  2003cited by this paper
• Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.

  2003influential reference
• Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.

  2003influential reference
• Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid.

  2003cited by this paper
• Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats.

  2003cited by this paper
• Melatonin for the Treatment of Tardive Dyskinesia

  2003cited by this paper
• Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia.

  2003influential reference
• Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats

  2003cited by this paper
• Early oxidative stress in the diabetic kidney: effect of DL-α-lipoic acid

  2003cited by this paper
• Excitatory mechanisms in neuroleptic‐induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide

  2001influential reference
• Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia.

  2001cited by this paper
• α‐Lipoic acid inhibits TNF‐a‐induced NF‐κB activation and adhesion molecule expression in human aortic endothelial cells

  2001cited by this paper
• Molecular aspects of lipoic acid in the prevention of diabetes complications.

  2001cited by this paper
• Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats.

  2001influential reference
• Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1.

  2001cited by this paper
• Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don.

  2001cited by this paper
• Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia

  2001cited by this paper
• Handbook of Antioxidants

  2001cited by this paper
• Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid.

  2001cited by this paper
• Nutraceuticals in Health and Disease Prevention

  2001cited by this paper
• Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study.

  2001cited by this paper
• Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells.

  2001cited by this paper
• Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase‐2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages

  2001cited by this paper
• Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-alpha-lipoic acid.

  2000cited by this paper
• Is melatonin treatment effective for tardive dyskinesia?

  2000cited by this paper
• Calcium channel blockers for neuroleptic-induced tardive dyskinesia.

  2000cited by this paper
• Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy.

  1999cited by this paper
• Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.

  1999influential reference
• Vitamin E in the Treatment of Tardive Dyskinesia

  1999cited by this paper
• Tardive Dyskinesia: Review of Treatments Past, Present, and Future

  1999cited by this paper
• Vitamin E (α-Tocopherol) in the Treatment of Tardive Dyskinesia: A Statistical Meta-Analysis

  1998cited by this paper
• Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.

  1998cited by this paper
• Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis.

  1998cited by this paper
• Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

  1998cited by this paper
• Long-term treatment effects of vitamin E for tardive dyskinesia.

  1998cited by this paper
• Roles of Lipid Peroxidation in Modulation of Cellular Signaling Pathways, Cell Dysfunction, and Death in the Nervous System

  1998cited by this paper
• Induction of Reactive Oxygen Species in Neurons by Haloperidol

  1998influential reference
• Redox regulation of cell functions by α‐lipoate: biochemical and molecular aspects

  1998cited by this paper
• Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts.

  1998cited by this paper
• Redox regulation of cell functions by alpha-lipoate: biochemical and molecular aspects.

  1998cited by this paper
• Induction of NF-κB Activity during Haloperidol-Induced Oxidative Toxicity in Clonal Hippocampal Cells: Suppression of NF-κB and Neuroprotection by Antioxidants

  1998cited by this paper
• The pharmacology of the antioxidant lipoic acid.

  1997cited by this paper
• Free radical pathology in schizophrenia: a review.

  1996cited by this paper
• Oxidative injury and potential use of antioxidants in schizophrenia.

  1996cited by this paper
• Inhibition by memantine of the development of persistent oral dyskinesias induced by long‐term haloperidol treatment of rats

  1996cited by this paper
• Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats.

  1995influential reference
• Haloperidol-induced cell death—mechanism and protection with vitamin E in vitro

  1995influential reference
• alpha-Lipoic acid as a biological antioxidant.

  1995cited by this paper
• The rat model of tardive dyskinesia: relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment.

  1995cited by this paper
• Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate

  1995cited by this paper
• Free radical mechanisms in schizophrenia and tardive dyskinesia.

  1994cited by this paper
• Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat.

  1994cited by this paper
• Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment

  1993cited by this paper
• Oxidative stress and thiol modification induced by chronic administration of haloperidol.

  1993influential reference
• Vitamin E in tardive dyskinesia: time course of effect after placebo substitution.

  1993cited by this paper
• The essential polyunsaturated fatty acids of Spirulina and our immune response

  1993cited by this paper
• Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association

  1993cited by this paper
• Vitamin E treatment of tardive dyskinesia.

  1993cited by this paper
• Treatment of tardive dyskinesia with vitamin E.

  1992cited by this paper
• Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats.

  1992cited by this paper
• Free radicals, antioxidants, and human disease: where are we now?

  1992cited by this paper
• Antioxidants in the treatment of schizophrenia.

  1992cited by this paper
• Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.

  1991cited by this paper
• Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

  1991cited by this paper
• Vitamin E in the treatment of tardive dyskinesia.

  1990cited by this paper
• Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia.

  1990cited by this paper
• Effects of chronic haloperidol on vitamin E levels and monoamine metabolism in rats fed normal and vitamin E deficient diets.

  1990cited by this paper
• Effects of chronic haloperidol on vitamin E levels and monoamine metabolism in rats fed normal and vitamin E deficient diets

  1990cited by this paper
• Predictors of Improvement in Tardive Dyskinesia Following Discontinuation of Neuroleptic Medication

  1990cited by this paper
• Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stress.

  1990cited by this paper
• Free Radicals and Tardive Dyskinesia

  1990cited by this paper
• Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats.

  1990cited by this paper
• Possible Involvement of Free Radicals in Neuroleptic‐Induced Movement Disorders Evidence from Treatment of Tardive Dyskinesia with Vitamin E

  1989cited by this paper
• Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

  1989cited by this paper
• Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on alpha-tocopherol.

  1989cited by this paper
• The catalepsy test: its ups and downs.

  1988cited by this paper
• Alpha-tocopherol in tardive dyskinesia.

  1987cited by this paper
• Estrogens as natural antioxidants of membrane phospholipid peroxidation

  1987cited by this paper
• ALPHA-TOCOPHEROL IN TARDIVE DYSKINESIA

  1987cited by this paper
• Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines.

  1987cited by this paper
• Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration.

  1986cited by this paper
• 1 – Oxidative Stress: Introductory Remarks

  1985cited by this paper
• Spontaneous and tardive dyskinesias: clinical and laboratory studies.

  1985cited by this paper
• Spontaneous and tardive dyskinesias: clinical and laboratory studies.

  1985cited by this paper

• Effects of Preventive Exposure to High Doses of Alpha-Lipoic Acid (ALA) on Testicular and Sperm Alterations Caused by Scrotal Heat Shock in Mice

  2025cites this paper
• Therapeutic applications of alpha-lipoic acid: A review of clinical and preclinical evidence (1998-2024).

  2025cites this paper
• The Impact of Flunixin Meglumine and Alpha-Lipoic Acid on Male Reproductive Parameters and the Protective Potential of Alpha-Lipoic Acid

  2025cites this paper
• α -lipoic acid supplementation reduces oxidative stress and inflammation in red skeletal muscle of insulin-resistant rats.

  2024cites this paper
• [Dopaminergic potential of domestic 3-hydroxypyridine and succinic acid derivatives and prospects for their therapeutic «retargeting»].

  2023cites this paper
• α-Lipoic Acid Reduces Ceramide Synthesis and Neuroinflammation in the Hypothalamus of Insulin-Resistant Rats, While in the Cerebral Cortex Diminishes the β-Amyloid Accumulation

  2022cites this paper
• α-Lipoic Acid Strengthens the Antioxidant Barrier and Reduces Oxidative, Nitrosative, and Glycative Damage, as well as Inhibits Inflammation and Apoptosis in the Hypothalamus but Not in the Cerebral Cortex of Insulin-Resistant Rats

  2022cites this paper
• Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial

  2022cites this paper
• Reflex memory theory of acquired involuntary motor and sensory disorders

  2021cites this paper
• Supplementation of Lipoic Acid, Zinc and Clopidogrel Reduces Mortality Rate and Incidence of Ventricular Arrhythmia in Experimental Myocardial Infarction

  2021cites this paper
• Investigation of the effects of cannabidiol on vacuous chewing movements, locomotion, oxidative stress and blood glucose in rats treated with oral haloperidol

  2020cites this paper
• Effect of herbal and nutritional products on the central nervous system effects of haloperidol: a systematic review

  2019cites this paper
• Caffeine inhibits Levodopa-Induced Potentiation of Haloperidol-Induced Catalepsy and Tardive Dyskinesia in Balb/ C Mice

  2018cites this paper
• Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.

  2018cites this paper
• Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.

  2018cites this paper
• Tardive dyskinesia update: treatment and management

  2018cites this paper
• Lipoic acid and haloperidol‐induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia

  2017influential citation
• Potential Ameliorative Effects of Alpha Lipoic Acid and Silymarin on Thioacetamide-Induced Hepatic Damage in Rats

  2017cites this paper
• Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats

  2017cites this paper
• Behavioral and neurochemical effects of alpha lipoic acid associated with omega-3 in tardive dyskinesia induced by chronic haloperidol in rats.

  2017cites this paper
• Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism

  2016influential citation
• Ginger and alpha lipoic acid ameliorate age-related ultrastructural changes in rat liver

  2016cites this paper
• Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation.

  2016cites this paper
• Alpha-lipoic acid treatment of acetaminophen-induced rat liver damage

  2015cites this paper
• Lipoic Acid: its antioxidant and anti-inflammatory role and clinical applications.

  2015cites this paper
• Protective Effect of Alpha Lipoic Acid against Phenytoin Induced Behavioral Abnormalities in Rats

  2015cites this paper
• Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia.

  2015cites this paper
• Nervous about developments in electron transfer-reactive oxygen species-oxidative stress mechanisms of neurotoxicity?

  2014cites this paper
• Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies

  2014cites this paper
• A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs by D. G. Cunningham Owens

  2014cites this paper
• Implication of the ERK/MAPK Pathway in Antipsychotics-induced Dopamine D2 Receptor Upregulation and in the Preventive Effects of (±)-α-lipoic acid in SH-SY5Y Neuroblastoma Cells

  2014influential citation
• α-Lipoic Acid Interaction with Dopamine D2 Receptor-Dependent Activation of the Akt/GSK-3β Signaling Pathway Induced by Antipsychotics: Potential Relevance for the Treatment of Schizophrenia

  2013influential citation
• Possible beneficial effect of peroxisome proliferator-activated receptor (PPAR)--α and γ agonist against a rat model of oral dyskinesia.

  2013cites this paper
• Sulforaphane protects SK‐N‐SH cells against antipsychotic‐induced oxidative stress

  2012cites this paper
• Antipsychotic‐induced DRD2 upregulation and its prevention by α‐lipoic acid in SH‐SY5Y Neuroblastoma cells

  2011cites this paper
• Protective Effect of Alpha-lipoic Acid Against Lead Acetate-Induced Oxidative Stress in the Bone Marrow of Rats

  2011cites this paper
• Animal models of tardive dyskinesia.

  2011cites this paper
• Comparative study between two animal models of extrapyramidal movement disorders: prevention and reversion by pecan nut shell aqueous extract.

  2011cites this paper
• Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity.

  2011cites this paper
• Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats

  2011cites this paper
• B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms

  2011influential citation
• EFFECTS OF COMBINED THERAPY WITH NIFEDIPINE AND MELATONIN ON HALOPERIDOL- INDUCED TARDIVE DYSKINESIA IN RATS

  2010cites this paper
• Send Orders of Reprints at Reprints@benthamscience.org Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species

  year unknowncites this paper